Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Children of Centenarians Often Live Longer, Develop Some Age-Related Diseases Later (opens in a new tab)

prnewswire.com · 2026-08-26

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One key claim is not backed by the study. One other point was not covered by the paper.

  • 4 supported
  • 1 not supported
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim isn't supported by the study. Four of six check out. One claim the study doesn't address.

  • 4 supported
  • 1 not supported
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not supportedThe researchers analyzed data from three long-running studies—LonGenity, the New England Centenarian Study, and UK Biobank—comparing 2,319 centenarians' offspring with 2,703 controls over follow-up periods of 16 years and 29 years.View evidenceHide evidence

As stated2,319 offspring; 2,703 controls; 16 years and 29 years of follow-up

Why this verdict

The three cohorts and 2,319 centenarian-offspring count are supported by the profile: 245 + 1,082 + 992 = 2,319. The cohort date ranges also support 16-year and 29-year follow-up windows. But the stated 2,703 controls is not supported and conflicts with the abstract-level sample counts supplied: total N across cohorts is 4,030, which implies 1,711 non-centenarian-offspring participants, not 2,703. Because the numerical comparison group size is a material part of the claim, the claim is unsupported as stated.

1

Study evidence

In the LonGenity cohort, centenarians' offspring had a lower hazard of incident stroke compared with control offspring.HR 0.27 (95% CI, 0.09–0.81)

“Three independent longitudinal cohorts were studied: LonGenity (2008-2024; New York City area)”
2

Study evidence

In the NECS within-cohort Cox models, offspring of centenarians had a reduced hazard of incident stroke compared with controls.HR 0.41 (95% CI 0.27–0.63)

“the New England Centenarian Study (NECS; 1995-2024; throughout the US)”
Claim 2 of 6Not coveredThe study, led by researchers at Albert Einstein College of Medicine, Boston University, and Tufts Medical Center, adds to evidence that exceptional longevity and healthy aging run in families and suggests that inherited biological factors may help explain those advantages beyond lifestyle.View evidenceHide evidence

Why this verdict

The family-longevity association is supported by the cohort design and findings, and the paper profile says the results support studying factors promoting healthy aging. However, at abstract depth the profile does not verify the listed lead institutions, does not report lifestyle/education/socioeconomic adjustment details, and does not directly establish that inherited biological factors explain the advantages beyond lifestyle. The headline-level speculative framing is hedged, but parts of the claim require details not available in the supplied abstract profile.

1

Study evidence

In the LonGenity cohort, centenarians' offspring had a lower hazard of incident stroke compared with control offspring.HR 0.27 (95% CI, 0.09–0.81)

“Three independent longitudinal cohorts were studied: LonGenity (2008-2024; New York City area)”
2

Study evidence

In the NECS within-cohort Cox models, offspring of centenarians had a reduced hazard of incident stroke compared with controls.HR 0.41 (95% CI 0.27–0.63)

“the New England Centenarian Study (NECS; 1995-2024; throughout the US)”
Claim 3 of 6SupportedAdults with at least one parent who reached age 100 lived longer and had substantially lower risks of cardiovascular disease and hypertension than people whose parents had shorter lifespans, according to a study published today in JAMA Network Open.View evidenceHide evidence

As stated42% lower risk of death, 33% lower risk of cardiovascular disease, 32% lower risk of hypertension

Why this verdict

The abstract-level profile supports the main associational finding: pooled meta-analysis showed lower hazards for death, cardiovascular disease, and hypertension among offspring of centenarians versus controls, with aggregate HRs matching the story’s stated magnitudes: death HR 0.58, CVD HR 0.67, and hypertension HR 0.68. This is observational evidence, but the claim is framed associationally.

1

Study evidence

Pooled analysis showed reduced hazard of death for offspring of centenarians compared with controls.HR 0.58 (95% CI, 0.41-0.81); delay 3.12 years (95% CI, 0.96-5.28 years)

“Meta-analyses identified consistently reduced hazards for death, CVD, and hypertension, with aggregate HR estimates of 0.58 ... for death, 0.67 ... for CVD, and 0.68 ... for hypertension”
Claim 4 of 6SupportedCompared with people whose parents had shorter lifespans, centenarians' offspring at any given age had a 42% lower risk of death, a 33% lower risk of cardiovascular disease, and a 32% lower risk of hypertension, and these outcomes tended to occur later in life by about three years for death and five years for hypertension.View evidenceHide evidence

As stated42% lower risk of death; 33% lower risk of cardiovascular disease; 32% lower risk of hypertension; death about 3 years later; hypertension about 5 years later

Why this verdict

The profile’s meta-analysis unit reports the same aggregate hazard ratios and delay estimates: death HR 0.58, CVD HR 0.67, hypertension HR 0.68, death delayed by 3.12 years, and hypertension delayed by 5.21 years. The claim is framed as an association rather than a causal effect, which matches the observational evidence.

1

Study evidence

Pooled analysis showed reduced hazard of death for offspring of centenarians compared with controls.HR 0.58 (95% CI, 0.41-0.81); delay 3.12 years (95% CI, 0.96-5.28 years)

“Meta-analyses identified consistently reduced hazards for death, CVD, and hypertension, with aggregate HR estimates of 0.58 ... for death, 0.67 ... for CVD, and 0.68 ... for hypertension”
Claim 5 of 6SupportedHaving a centenarian parent did not clearly confer protection against stroke or cancer, according to the story.View evidenceHide evidence

Why this verdict

The profile states no significant association with cancer and notes that stroke reductions were seen in LonGenity and NECS but not reported as a consistent pooled reduction across all three cohorts. The story’s hedged statement that protection against stroke or cancer was not clear is consistent with the abstract-level evidence, though it compresses the nuance that stroke was significantly lower in two cohorts.

1

Study evidence

In the LonGenity cohort, centenarians' offspring had a lower hazard of incident stroke compared with control offspring.HR 0.27 (95% CI, 0.09–0.81)

“Three independent longitudinal cohorts were studied: LonGenity (2008-2024; New York City area)”
2

Study evidence

In the NECS within-cohort Cox models, offspring of centenarians had a reduced hazard of incident stroke compared with controls.HR 0.41 (95% CI 0.27–0.63)

“the New England Centenarian Study (NECS; 1995-2024; throughout the US)”
Claim 6 of 6SupportedThe study was not designed to identify the specific inherited traits involved, but the authors say the findings provide a rationale for studying centenarians and their families to uncover biological factors that promote longevity and protect against age-related disease.View evidenceHide evidence

Why this verdict

The supplied profile describes an observational cohort/meta-analysis study of parental longevity and time-to-event outcomes, not a study designed to identify specific inherited traits. The profile discussion also says the findings support using offspring of centenarians as a research model for factors promoting healthy aging. The story’s claim is appropriately hedged and does not assert that the study identified those traits.

1

Study evidence

In the LonGenity cohort, centenarians' offspring had a lower hazard of incident stroke compared with control offspring.HR 0.27 (95% CI, 0.09–0.81)

“Three independent longitudinal cohorts were studied: LonGenity (2008-2024; New York City area)”
2

Study evidence

In the NECS within-cohort Cox models, offspring of centenarians had a reduced hazard of incident stroke compared with controls.HR 0.41 (95% CI 0.27–0.63)

“the New England Centenarian Study (NECS; 1995-2024; throughout the US)”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The paper is based on observational, non-random cohort comparisons defined by parental lifespan, so residual confounding and causal interpretation are inherent concerns.

    The story frames the main results associationally, but its caveats do not explicitly mention the observational, non-random design or inherent potential for confounding. This is an interpretation-changing limitation.

    From longitudinal cohort (secondary data) — within-cohort survival analysis; longitudinal cohort analysis (observational); se

  • The supplied abstract profile does not report covariate adjustment details for lifestyle, education, socioeconomic status, missing data, censoring, or model diagnostics.

    The story says the findings remained after adjustment for lifestyle, education, and socioeconomic factors, but that adjustment claim is not verifiable from the supplied abstract-level paper profile and the lack of abstract-level covariate detail is not acknowledged.

    From longitudinal cohort (secondary data) — within-cohort survival analysis; longitudinal cohort analysis (observational); se

  • Cohorts differed in setting, dates, sample size, and enrollment age distributions, which may affect comparability and pooled estimates.

    The story names the cohorts and follow-up windows but does not mention the profile’s limitation that cohort differences may affect generalizability and pooling.

    From longitudinal cohort (secondary data) — within-cohort survival analysis; longitudinal cohort analysis (observational); se

4 things the story did carry across
  • Pooled meta-analysis found reduced hazards for death, cardiovascular disease, and hypertension among centenarians’ offspring, with HRs of 0.58, 0.67, and 0.68, respectively.
  • The meta-analysis estimated delayed death by 3.12 years and delayed hypertension onset by 5.21 years among centenarians’ offspring.
  • Stroke results were not uniform across all three cohorts: reduced hazards were reported in LonGenity and NECS, but not as a consistent pooled reduction across all cohorts in the abstract profile.
  • No significant association between parental longevity and cancer incidence was found.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

4

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataDetermine whether centenarians’ offspring have delayed onset of mortality and major age-associated morbidities compared with controls, consistently across three independent longitudinal cohorts.longitudinal cohort (secondary data) — within-cohort survival analysisExpand

In plain English

Within the LonGenity cohort (2008–2024, New York City area; N=480, 245 offspring of centenarians), the authors used within-cohort Cox proportional hazards models to compare centenarians' offspring versus control offspring for time-to-event outcomes (death and incident cardiovascular disease, cancer, hypertension, and stroke). The abstract reports a significantly reduced hazard of stroke for centenarians' offspring in LonGenity (HR 0.27, 95% CI 0.09–0.81). The abstract does not provide cohort-specific hazard ratios for the other evaluated outcomes for LonGenity.

Key findings

  • In the LonGenity cohort, centenarians' offspring had a lower hazard of incident stroke compared with control offspring.HR 0.27 (95% CI, 0.09–0.81)
  • Within LonGenity, the authors evaluated time to death and incident cardiovascular disease, cancer, and hypertension using Cox regression comparing centenarians' offspring versus controls.
“Three independent longitudinal cohorts were studied: LonGenity (2008-2024; New York City area)”
What this piece can’t prove
  • Observational (non-random) exposure definition based on parental lifespan; potential for confounding is inherent to the study design.

2 further details could not be confirmed from the summary.

2secondary dataDetermine whether centenarians’ offspring have delayed onset of mortality and major age-associated morbidities compared with controls, consistently across three independent longitudinal cohorts.longitudinal cohort analysis (observational)Expand

In plain English

Within the New England Centenarian Study (NECS; 1995-2024), participants were classified by parental longevity (offspring of at least one parent who reached ≥100 years vs controls) and followed for time-to-event outcomes. Cox proportional hazards regression was used within the cohort to estimate hazard ratios and delays in expected age of incidence for death and four age-associated morbidities (cardiovascular disease, cancer, hypertension, stroke). The NECS sample included 1,566 participants (median enrollment age 71 years, 59% women), of whom 1,082 (69%) were offspring of centenarians. The abstract reports a within-cohort reduced hazard for stroke in NECS (HR 0.41, 95% CI 0.27–0.63); NECS-specific effect estimates for other outcomes are not reported in the abstract.

Key findings

  • In the NECS within-cohort Cox models, offspring of centenarians had a reduced hazard of incident stroke compared with controls.HR 0.41 (95% CI 0.27–0.63)
  • Within NECS, differences in age at death and age at onset of CVD, cancer, and hypertension were evaluated using Cox models, but NECS-specific effect estimates for these outcomes are not reported in the abstract.
“the New England Centenarian Study (NECS; 1995-2024; throughout the US)”
What this piece can’t prove
  • Abstract does not report covariates used in Cox models, adjustment strategy, or methods for handling missing data and censoring for NECS analyses.

2 further details could not be confirmed from the summary.

3secondary dataDetermine whether centenarians’ offspring have delayed onset of mortality and major age-associated morbidities compared with controls, consistently across three independent longitudinal cohorts.secondary data cohort analysisExpand

In plain English

Within the UK Biobank cohort (2006–2022), investigators compared offspring with at least one parent who reached age 100 versus control offspring using within-cohort Cox proportional hazards models to evaluate time to death and incident cardiovascular disease, cancer, hypertension, and stroke. The UK Biobank sample (n = 1984; 992 offspring of centenarians) contributed to the paper's meta-analyses that reported reduced aggregate hazards for death, CVD, and hypertension and no significant association with cancer; cohort-specific hazard estimates are not reported in the abstract and stroke reductions were reported only in the two US cohorts.

Key findings

  • Within the UK Biobank cohort (n = 1984; 992 offspring of centenarians), investigators performed within-cohort Cox PH analyses comparing centenarian offspring versus controls for death and incident CVD, cancer, hypertension, and stroke.
  • Stroke hazard reduction was reported only in two US cohorts (LonGenity and NECS) and not in the UK Biobank according to the abstract-level summary.
“and the UK Biobank (2006-2022; throughout the UK)”
What this piece can’t prove
  • UK Biobank has different ascertainment and a younger enrollment age range (median 65 years, range 42–71) compared with the US cohorts, which may affect generalizability and comparability across cohorts (as noted in the paper abstract).

2 further details could not be confirmed from the summary.

4secondary dataSynthesize (meta-analyze) cohort-specific hazard estimates to assess cross-cohort consistency and aggregate effect sizes for mortality and morbidity outcomes.meta-analysisExpand

In plain English

The study pooled cohort-specific hazard ratios from three longitudinal cohorts (LonGenity, NECS, UK Biobank) to estimate aggregated associations of parental exceptional longevity with offspring mortality and age-associated morbidities. Meta-analyses reported reduced hazards for death, cardiovascular disease, and hypertension (with estimated delays for death and hypertension), stroke reductions apparent in two cohorts (LonGenity and NECS) but not uniformly, and no significant associations with cancer.

Key findings

  • Pooled analysis showed reduced hazard of death for offspring of centenarians compared with controls.HR 0.58 (95% CI, 0.41-0.81); delay 3.12 years (95% CI, 0.96-5.28 years)
  • Pooled analysis showed reduced hazard of cardiovascular disease (CVD) for offspring of centenarians.HR 0.67 (95% CI, 0.46-0.97)
“Meta-analyses identified consistently reduced hazards for death, CVD, and hypertension, with aggregate HR estimates of 0.58 ... for death, 0.67 ... for CVD, and 0.68 ... for hypertension”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

Offspring of Centenarians Exhibit Reduced Risk and Delay of Age-Associated Morbidity and Mortality: Results from the LonGenity, New England Centenarian, and UK Biobank Studies

2025 · Crossref

Source (opens in a new tab)
Candidate

Trends and Mortality in Hip Fracture Surgery Among Octogenarians, Nonagenarians, and Centenarians: High Postoperative Mortality in Centenarians Despite Few Comorbidities

2024 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.